Amgen to buy Horizon Therapeutics in… Amgen is spending more than $26 billion to dive deeper into rare disease treatments with the acquisition of…
Amgen close to deal to buy Horizon Therapeutics… Amgen is close to a deal to acquire Horizon Therapeutics in a transaction worth as much as $20bn, according…
Experimental obesity drug shows promise in… Amgen’s small Phase I trial found that patients maintained their weight loss for 70 days after receiving the…